Method of site-specific alteration of RNA and production of encoded polypeptides
AssigneeWorcester Foundation for Experimental Biology
InventorsThoru Pederson, Sudhir Agrawal, Sandra Mayrand, Paul C. Zamecnik
Life of this patent
Estimating the term…
Abstract
A method of site-directed alteration (removal or removal followed by replacement) of selected nucleotides in an RNA molecule, as well as to mixed phosphate backbone oligonucleotides useful in the method. It further relates to a method of producing polypeptides or proteins encoded by the RNA molecule altered by the present method. Through use of the present method, site-directed cleavage of an RNA molecule is effected, followed by excision of the selected or target segment of the RNA molecule.
Claims12
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that activate RNase H and a 3' segment of nucleotides that do not activate RNase H, wherein the 5' segment of nucleotides comprises nucleotide phosphodiesters and wherein the 3' segment of nucleotides comprises two or more contiguous nucleotide alkylphosphonates.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that activate RNase and a 3' segment of nucleotides that do not activate Rnase H, wherein the 5' segment of nucleotides comprises nucleotide phosphodiesters and wherein the 3' segment of nucleotides comprises nucleotide phosphoromorpholidates.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that activate RNase and a 3' segment of nucleotides that do not activate Rnase H, wherein the 5' segment of nucleotides comprises nucleotide phosphodiesters and wherein the 3' segment of nucleotides comprises nucleotide phosphoramidates.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that do not activate RNase H and a 3' segment of nucleotides that activate RNase H wherein the 5' segment of nucleotides comprises three or more contiguous nucleotide alkylphosphonates and the 3' segment of nucleotides comprises nucleotide phosphodiesters.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that do not activate RNase H and a 3' segment of nucleotides that activate RNase H wherein the 5' segment of nucleotides comprises nucleotide phosphoromorpholidates and the 3' segment of nucleotides comprises nucleotide phosphodiesters.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that do not activate RNase H and a 3' segment of nucleotides that activate RNase H wherein the 5' segment of nucleotides comprises nucleotide phosphoramidates and the 3' segment of nucleotides comprises nucleotide phosphodiesters.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that activate RNase and a 3' segment of nucleotides that do not activate RNase H, wherein the 5' segment of nucleotides comprises nucleotide phosphorothioates and wherein the 3' segment of nucleotides comprises nucleotide alkylphosphonates.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that activate RNase and a 3' segment of nucleotides that do not activate RNase H, wherein the 5' segment of nucleotides comprises nucleotide phosphorothioates and wherein the 3' segment of nucleotides comprises nucleotide phosphoromorpholidates.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that activate RNase and a 3' segment of nucleotides that do not activate RNase H, wherein the 5' segment of nucleotides comprises nucleotide phosphorothioates and wherein the 3' segment of nucleotides comprises nucleotide phosphoramidates.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that do not activate RNase H and a 3' segment of nucleotides that activate RNase H wherein the 5' segment of nucleotides comprises nucleotide alkylphosphonates and the 3' segment of nucleotides comprises nucleotide phosphorothioates.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that do not activate RNase H and a 3' segment of nucleotides that activate RNase H wherein the 5' segment of nucleotides comprises nucleotide phosphoromorpholidates and the 3' segment of nucleotides comprises nucleotide phosphorothioates.
A mixed phosphate backbone oligonucleotide comprising a 5' segment of nucleotides that do not activate RNase H and a 3' segment of nucleotides that activate RNase H wherein the 5' segment of nucleotides comprises nucleotide phosphoramidates and the 3' segment of nucleotides comprises nucleotide phosphorothioates.
Dependencies are inferred from the claim text.